Viyash Scientific Ltd is Rated Hold by MarketsMOJO
NiveshIQ
NSE: VIYASH · Healthcare
Viyash Scientific Ltd.
₹257.60▼ ₹2.85 (-1.09%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on VIYASH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Viyash Scientific Ltd.
Viyash Scientific Limited, headquartered in Hyderabad, operates as a veterinary pharmaceutical company with a presence in India, the United States, Spain, and other international markets. The company’s core business includes manufacturing active pharmaceutical ingredients, finished dosage formulations, and providing analytical and formulation services for cattle and poultry. In FY26, Viyash reported a 64% EBITDA growth post-merger, with total revenue of ₹3,575 crore and net income of ₹211 crore, underscoring robust profitability. Recent developments include securing Italian regulatory approval for the BioForLife acquisition and expanding its product portfolio through strategic acquisitions. Competitively, Viyash leverages its global footprint and diversified service offerings to differenti
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,369 Cr -3.70% | ₹1,935 Cr +41.30% | ₹3,420 Cr |
| EBITDA Margin | 4.46% | 11.73% | 20.35% |
| Net Profit | -75.40% | ₹67.00 Cr -323.30% | ₹268.86 Cr |
| EPS | ₹-1.45 | ₹2.51 | ₹4.09 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Viyash Scientific Ltd is Rated Hold by MarketsMOJO
Viyash Scientific Limited Honoured For CSR Work In Healthcare And Community Development
🔒
+ 3 more stories about Viyash Scientific Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹946 Cr, PAT ₹79 Cr, EPS ₹1.51, EBITDA margin 19.7%. Growth context: revenue QoQ +2.9%, PAT QoQ +19.4%. Street verdict: miss.
Recent corporate activity highlights product launches, approvals, and therapy-mix improvement and geographic expansion a...
FY26 (last completed FY): revenue ₹3, 420 Cr, PAT ₹269 Cr, EBITDA margin 20.4%, EPS ₹4.09. Street consensus for FY27e: r...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for VIYASH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track VIYASH alongside your other holdings
Unlock full VIYASH research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Viyash Scientific Ltd.?
NiveshIQ detects active intelligence signals for Viyash Scientific Ltd. (VIYASH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Viyash Scientific Ltd.?
Viyash Scientific Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,120,008.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.